Search
You have searched for "NexPAP"
Showing 1-6 of 6
The NexPAP programme
NexPAP is a programme designed to assist Malaysian patients who have been diagnosed with liver cancer (hepatocellular carcinoma or HCC), and have been prescribed by their doctors to use sorafenib.
Surviving liver cancer
The NexPAP Patient Assistance Programme commemorates its third anniversary.
A life worth living
Beneficiaries from the NexPAP patient assistance programme for treatment of liver cancer celebrate their 'second-chance' in life.
A common cancer
THE liver is the second largest organ in the body, and performs a variety of functions that are vital to life. These include the filtering and processing of blood; bile production; producing proteins, glucose and cholesterol; storing fat-soluble vitamins, glycogen and iron; metabolising drugs, glucose and haemoglobin; and even a role in immunity.
The drug that could
SORAFENIB was first approved by the US Food and Drug Administration (FDA) for advanced renal carcinoma, or kidney cancer.
A jab against liver cancer
The majority of those with liver cancer have chronic hepatitis or cirrhosis, and understandably, older patients with longstanding liver disease are more likely to develop the cancer.
